Visual loss treated with osimertinib: A case report
Current Problems in Cancer: Case Reports, 2022 Visual loss secondary to choroidal metastases is a rare initial presentation of lung cancer. Osimertinib is a third generation TKI used in treating advanced EGFR-mutation positive lung cancer.
Dimitrios Drekolias +2 more
doaj +1 more source
A review of the role of ultrasound biomicroscopy in glaucoma associated with rare diseases of the anterior segment [PDF]
, 2016 Ultrasound biomicroscopy is a non-invasive imaging technique, which allows high-resolution evaluation of the anatomical features of the anterior segment of the eye regardless of optical media transparency.
Abdolrahimzadeh, B +5 more
core +2 more sources
MYCN Amplification in RB1‐Inactivated Retinoblastoma: Association With High‐Risk Features
Pediatric Blood &Cancer, Volume 73, Issue 6, June 2026.ABSTRACT Background MYCN amplification occurs in a subset of retinoblastoma cases, both with and without RB1 inactivation. It has been suggested that retinoblastomas with MYCN amplification represent a distinct entity with more aggressive clinical behavior.
Kyriaki Papaioannou +9 more
wiley +1 more source
Case Reports in Urology, 2014 Bladder cancer is the second most common genitourinary malignancy and has variable metastatic potential; however, choroidal and cutaneous metastases are extremely rare. Generally, a patient with these uncommon metastases has a very poor prognosis.
Yozo Mitsui +9 more
doaj +1 more source
Spontaneous regression of choroidal metastasis from renal cell carcinoma
American Journal of Ophthalmology Case Reports, 2023 Purpose: To report a case of an elderly man who presented with a choroidal metastasis from renal cell carcinoma that spontaneously regressed prior to any local or systemic treatment. Observations: An 82-year-old man without a history of metastatic cancer
Sean M. Rodriguez +5 more
doaj +1 more source
Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma [PDF]
, 2015 AIMS: The aim of the present study was to immunohistochemically investigate the expression and prognostic significance of putative cancer stem cell markers CD117 (c-kit), CD34, CD20 and CD15 in a cohort of patients with primary choroidal and ciliary ...
Dotlić, Snježana +5 more
core +1 more source
Survival impact of second primary cutaneous and non‐cutaneous melanoma in melanoma survivors
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 823-834, May 2026.In this US population‐based cohort study, melanoma survivors diagnosed with regional/distant‐stage SPCM or SPNCM had worse survival compared to those with a single melanoma. Abstract Background Melanoma survivors have a high risk of developing second primary neoplasms, both cutaneous melanoma (SPCM) and non‐cutaneous melanoma (SPNCM), but little is ...
Jingjing Xie +3 more
wiley +1 more source
Case Reports in Oncology, 2011 Choroidal melanoma is an insidious tumor frequently causing late liver metastases which are associated with a poor outcome. Since metastatic liver lesions are potentially resectable with curative intention, tight follow-up schedules after treatment of ...
Enrico N. De Toni +3 more
doaj +1 more source
Ultrabiomicroscopic imaging of choroidal metastases underlying an anterior scleritis
The Pan-American Journal of Ophthalmology, 2021 Tumor-associated masquerading anterior scleritis (AS) is a rare syndrome with few case reports in the medical literature. Imaging studies play a crucial role in the correct diagnosis of this entity. Ultrabiomicroscopy (UBM) is a vital imaging tool in the
Lucas A Garza-Garza +3 more
doaj +1 more source
Characterization of Luteinizing hormone-releasing hormone (LH-RH-I) receptor type I as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines [PDF]
, 2019 K
Dobos, Nikoletta +8 more
core +1 more source